Search Results - "Oster, C"

In situ forming parenteral drug delivery systems: an overview by Packhaeuser, C.B, Schnieders, J, Oster, C.G, Kissel, T

“…Biodegradable injectable in situ forming drug delivery systems represent an attractive alternative to microspheres and implants as parenteral depot systems…”
Get full text

Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial by Guberina, N, Pöttgen, C, Kebir, S, Lazaridis, L, Scharmberg, C, Lübcke, W, Niessen, M, Guberina, M, Scheffler, B, Jendrossek, V, Jabbarli, R, Pierscianek, D, Sure, U, Schmidt, T, Oster, C, Hau, P, Grosu, A L, Stuschke, M, Glas, M, Nour, Y, Lüdemann, L

“…Glioblastoma is a rapidly proliferating tumor. Patients bear an inferior prognosis with a median survival time of 14-16 months. Proliferation and repopulation…”
Get full text

Transcriptomics reveals transient and dynamic muscle fibrosis and atrophy differences following spinal cord injury in rats by Kok, Hui Jean, Fletcher, Drew B., Oster, Jacob C., Conover, Christine F., Barton, Elisabeth R., Yarrow, Joshua F.

“…Background The rate and magnitude of skeletal muscle wasting after severe spinal cord injury (SCI) exceeds most other disuse conditions. Assessing the time…”
Get full text

Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination by Oster, C.G., Kim, N., Grode, L., Barbu-Tudoran, L., Schaper, A.K., Kaufmann, S.H.E., Kissel, T.

“…Cationic microparticles for DNA adsorption were formulated by blending poly(lactide-co-glycolide) (PLGA) (50 : 50), with different cationic agents, either PEI…”
Get full text

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo by Dirschka, T., Radny, P., Dominicus, R., Mensing, H., Brüning, H., Jenne, L., Karl, L., Sebastian, M., Oster-Schmidt, C., Klövekorn, W., Reinhold, U., Tanner, M., Gröne, D., Deichmann, M., Simon, M., Hübinger, F., Hofbauer, G., Krähn-Senftleben, G., Borrosch, F., Reich, K., Berking, C., Wolf, P., Lehmann, P., Moers-Carpi, M., Hönigsmann, H., Wernicke-Panten, K., Helwig, C., Foguet, M., Schmitz, B., Lübbert, H., Szeimies, R.-M.

“…Summary Background  Photodynamic therapy (PDT) with 5‐aminolaevulinic acid (ALA) or its methylester [methyl‐5‐aminolaevulinate (MAL) or…”
Get full text

Neurological examination course in an interactive webinar as a solution during a pandemic. An overview of the implementation, optimization as well as critical considerations by Oster, C, Farhood, I, Klebe, S, Kleinschnitz, C, Peters, Lorenz

“…The COVID-19 pandemic made the traditional bedside teaching inaccessible for medical students. Within a short period of time, established bedside teaching…”
Get full text

Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis by Dirschka, T., Radny, P., Dominicus, R., Mensing, H., Brüning, H., Jenne, L., Karl, L., Sebastian, M., Oster-Schmidt, C., Klövekorn, W., Reinhold, U., Tanner, M., Gröne, D., Deichmann, M., Simon, M., Hübinger, F., Hofbauer, G., Krähn-Senftleben, G., Borrosch, F., Reich, K., Berking, C., Wolf, P., Lehmann, P., Moers-Carpi, M., Hönigsmann, H., Wernicke-Panten, K., Hahn, S., Pabst, G., Voss, D., Foguet, M., Schmitz, B., Lübbert, H., Szeimies, R.-M.

“…Summary Background  Two phase III trials of photodynamic therapy (PDT) with BF‐200 ALA, a recently approved nanoemulsion formulation of 5‐aminolaevulinic acid…”
Get full text

Time-lapse analysis and mathematical characterization elucidate novel mechanisms underlying muscle morphogenesis by Snow, Chelsi J, Goody, Michelle, Kelly, Meghan W, Oster, Emma C, Jones, Robert, Khalil, Andre, Henry, Clarissa A

“…Skeletal muscle morphogenesis transforms short muscle precursor cells into long, multinucleate myotubes that anchor to tendons via the myotendinous junction…”
Get full text

Resentment, hate, and hope in amyotrophic lateral sclerosis by Oster, C, Pagnini, F

“…Amyotrophic lateral sclerosis (ALS) is a fatal and progressive neurodegenerative disease. Despite much research having been conducted about psychological…”
Get full text

Comparative study of DNA encapsulation into PLGA microparticles using modified double emulsion methods and spray drying techniques by Oster, C. G., Kissel, T.

“…Recently, several research groups have shown the potential of microencapsulated DNA as adjuvant for DNA immunization and in tissue engineering approaches…”
Get full text

Two cases of squamous cell carcinoma treated with topical imiquimod 5 by Oster‐Schmidt, C

“…ABSTRACT We report the first two cases of squamous cell carcinoma successfully treated with imiquimod 5% cream as a monotherapy. Imiquimod is a new…”
Get full text

Cardiac Disease of Raptors by Oster, Seth C, Pariaut, Romain

“…Cardiac disease, in its various presentations, is being recognized as a common raptor health problem. Evidence suggests that the prevalence of cardiac disease…”
Get more information

Visceral Infection Caused by Leishmania tropica in Veterans of Operation Desert Storm by Magill, Alan J, Grogl, Max, Gasser, Robert A, Sun, Wellington, Oster, Charles N

“…The deployment of over 500,000 soldiers to the Arabian peninsula during Operation Desert Storm exposed immunologically naive hosts to infectious pathogens…”
Get full text

Characterization of the A549 Cell Line as a Type II Pulmonary Epithelial Cell Model for Drug Metabolism by Foster, Kimberly A., Oster, Christine G., Mayer, Mary M., Avery, Michael L., Audus, Kenneth L.

“…Multiple cell types contribute to the pulmonary barrier including Type I and Type II alveolar epithelium. The objective of this research was to establish and…”
Get full text

Pathology in Practice by Piras, Ilaria M, Sheahan, Kieran, Shiel, Robert E, Shorten, Eimear, Jahns, Hanne

Get full text

Cutaneous Leishmaniasis following Local Trauma: A Clinical Pearl by Wortmann, Glenn W., Aronson, Naomi E., Miller, Robert S., Blazes, David, Oster, Charles N.

“…Cutaneous leishmaniasis is acquired from the bite of an infected sand fly and can result in chronic skin lesions that develop within weeks to months after a…”
Get full text

Is sexuality a problem? A follow-up of patients with severe burns 6 months to 7 years after injury by Öster, C, Sveen, J

“…Highlights • Sexuality scores improved over time, even up to 7 years after-burn, in both men and women. • Women were less satisfied than men, as measured with…”
Get full text

Safety and Efficacy of Intravenous Sodium Stibogluconate in the Treatment of Leishmaniasis: Recent U.S. Military Experience by Aronson, Naomi E., Wortmann, Glenn W., Johnson, Steven C., Jackson, Joan E., Gasser, Robert A., Magill, Alan J., Endy, Timothy P., Coyne, Philip E., Grogl, Max, Benson, Paul M., Beard, Jeffrey S., Tally, John D., Gambel, Jeffrey M., Kreutzer, Richard D., Oster, Charles N.

“…The efficacy and toxicity of sodium stibogluconate (SSG) at a dosage of 20 mg/(kg×d) for either 20 days (for cutaneous disease) or 28 days (for visceral,…”
Get full text

Plasmodium falciparum incidence relative to entomologic inoculation rates at a site proposed for testing malaria vaccines in western Kenya by Beier, J C, Oster, C N, Onyango, F K, Bales, J D, Sherwood, J A, Perkins, P V, Chumo, D K, Koech, D V, Whitmire, R E, Roberts, C R

“…Relationships between Plasmodium falciparum incidence and entomologic inoculation rates (EIRs) were determined for a 21-month period in Saradidi, western…”
Get more information

The Educated Guess: Determining Drug Doses in Exotic Animals Using Evidence-Based Medicine by Visser, Marike, Oster, Seth C

“…Lack of species-specific pharmacokinetic and pharmacodynamic data is a challenge for pharmaceutical and dose selection. If available, dose extrapolation can be…”
Get more information